Lipid catabolism via CPT1 as a therapeutic target for prostate cancer

Por Schlaepfer, Isabel R., Rider, Leah, Rodrigues, Lindsey Ulkus, Gijón, Miguel A., Pac, Colton T., Romero, Lina, Cimic, Adela, Sirintrapun, S. Joseph, Glodé, L. Michael, Eckel, Robert H., Cramer, Scott D.
Publicado em 2014

Inhibition of Lipid Oxidation Increases Glucose Metabolism and Enhances 2-Deoxy-2-[(18)F]Fluoro-d-Glucose Uptake in Prostate Cancer Mouse Xenografts

Por Schlaepfer, Isabel R., Glodé, L. Michael, Hitz, Carolyn A., Pac, Colton T., Boyle, Kristen E., Maroni, Paul, Deep, Gagan, Agarwal, Rajesh, Lucia, Scott M., Cramer, Scott D., Serkova, Natalie J., Eckel, Robert H.
Publicado no Mol Imaging Biol (2015)

Coordinate loss of MAP3K7 and CHD1 promotes aggressive prostate cancer

Por Rodrigues, Lindsey Ulkus, Rider, Leah, Nieto, Cera, Romero, Lina, Karimpour-Fard, Anis, Loda, Massimo, Lucia, M. Scott, Wu, Min, Shi, Lihong, Cimic, Adela, Sirintrapun, S. Joseph, Nolley, Rosalie, Pac, Colton, Chen, Haitao, Peehl, Donna M., Xu, Jianfeng, Liu, Wennuan, Costello, James C., Cramer, Scott D.
Publicado no Cancer Res (2015)